Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy

por Mo, Fengzhen, Duan, Siliang, Jiang, Xiaobing, Yang, Xiaomei, Hou, Xiaoqiong, Shi, Wei, Carlos, Cueva Jumbo Juan, Liu, Aiqun, Yin, Shihua, Wang, Wu, Yao, Hua, Yu, Zihang, Tang, Zhuoran, Xie, Shenxia, Ding, Ziqiang, Zhao, Xinyue, Hammock, Bruce D., Lu, Xiaoling
Publicado 2021